NICE says anti-dementia drugs should be used only for moderate Alzheimer's diseaseBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7572.774-c (Published 12 October 2006) Cite this as: BMJ 2006;333:774
- Michael Day
The National Institute for Health and Clinical Excellence (NICE) confirmed its decision this week to recommend the use of cholinesterase inhibitors only for moderate Alzheimer's disease and not for mild disease.
Andrew Dillon, chief executive of the body, which advises on the use of drugs in the NHS, said, “Alzheimer's is a cruel and devastating illness, and we realise that today's announcement will be disappointing to people with Alzheimer's and those who treat and care for them.
“But we have to be honest and say that based on all …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial